Munich University Hospital
Significantly Longer Survival In Refractory Breast Cancer With The Addition Of Eganelisib To Standard Treatment!
City of Hope NationalMedical Center
Royal Brompton Hospital
New Findings Confirm: Excellent Data On This Bipotent Antibody Drug Against Ovarian Cancer!
Pre-Operative Immunotherapy And More Than Half Of The Tumours In This Type Of Skin Cancer Disappear Completely!
